Quidel Corporation Influenza Test Selected for FluSTAR® Surveillance Program

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, announced today that the QuickVue brand Influenza A+B test is the rapid flu test selected by Roche for use in over 400 physician offices participating in the FluSTAR surveillance program during the 2008-09 season.

MORE ON THIS TOPIC